Local elections in Donbass still some way off, says Ukrainian ministerWorld October 28, 2:39
Israel’s emotions are over top regarding UNESCO resolutions on Jerusalem - GatilovRussian Politics & Diplomacy October 28, 2:28
Russia speaks against politicization of probe into chemical attacks in Syria - GatilovRussian Politics & Diplomacy October 28, 2:25
UN, OPCW’s conclusions on Syria’s involvement in chemical attacks unconvincing - ChurkinRussian Politics & Diplomacy October 28, 2:00
Russian DefMin surprised by UNICEF inaction amid growing terrorist activity in SyriaRussian Politics & Diplomacy October 27, 23:14
Russian Defense Ministry: Video of airstrike on Syrian school doctored upRussian Politics & Diplomacy October 27, 21:22
Putin says its too early for him to retireSociety & Culture October 27, 21:10
Putin urges US not to provoke Russia to actively protect national interestsRussian Politics & Diplomacy October 27, 20:20
NATO’s actions create risks to European security — Russian NATO envoyRussian Politics & Diplomacy October 27, 19:52
SAN DIEGO, Aug. 11, 2014 /PRNewswire/ -- ResMed (NYSE: RMD) today announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement.
ResMed, a pioneer in the treatment of sleep-disordered breathing (SDB), has been the industry's premier innovator, with award winning customer-centric products that have significantly improved patient acceptance and adherence to SDB therapy.
Ecosystem Approach Brings Increased Efficiency and Efficacy to SDB Treatment
"With Air Solutions, we're creating a new beginning in patient care," said Don Darkin, president of the ResMed Sleep-Disordered Breathing Business Unit. "As we unveil each Air Solutions component, our signature differentiation of superior performance and comfort will be underscored, made even stronger with groundbreaking technology that helps providers become more connected with their patients."
Air Solutions comprises components that, together, create a comprehensive end-to-end ecosystem that directly addresses the pain points for each stakeholder in the patient's therapy, including physicians, sleep labs, home medical equipment providers, and the patients themselves. The ecosystem approach, Darkin says, can increase efficiency and treatment efficacy by keeping providers informed and patients engaged. Included in the Air Solutions platform are:
ApneaLink Air and AirFit masks are available now in the U.S. and other select markets. The AirSense 10 and AirView will be available in the U.S. and Australia on Aug. 18, and other markets later this calendar year. The AirCurve 10 Series and myAir will also be available later this calendar year.
ResMed changes lives by developing, manufacturing and distributing medical equipment for treating, diagnosing, and managing sleep-disordered breathing, COPD, and other chronic diseases. We develop innovative products and solutions to improve the health and quality of life of those who suffer from these conditions, and we work to raise awareness of the potentially serious health consequences of untreated sleep-disordered breathing. For more information on ResMed, visit www.resmed.com.
Contact for News Media:
Gretchen Griswold Director, Global Corporate Communications
Contact for Investors:
Agnes Lee Senior Director, Investor Relations